ISTRADEFYLLINE
| Brand name | NOURIANZ |
|---|---|
| Active ingredient | ISTRADEFYLLINE |
| Strength | 40MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2019 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7727993 | January 2028 | product |
| 8318201 | September 2027 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.